$ELST
ELECTRONIC SYSTEMS TECHNOLOGY INC

2024 Q3 Form 10-Q Financial Statement

#000107997324001090 Filed on July 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $293.9K $333.6K $585.2K
YoY Change -14.23% -43.0% 40.38%
Cost Of Revenue $145.4K $155.8K $268.6K
YoY Change -18.5% -42.0% 40.33%
Gross Profit $148.5K $177.8K $316.6K
YoY Change -9.6% -43.85% 40.42%
Gross Profit Margin 50.52% 53.29% 54.1%
Selling, General & Admin $193.2K $219.1K $234.9K
YoY Change 2.19% -6.7% 18.03%
% of Gross Profit 130.09% 123.27% 74.19%
Research & Development $28.24K $35.08K $28.02K
YoY Change 8.13% 25.2% -38.9%
% of Gross Profit 19.01% 19.73% 8.85%
Depreciation & Amortization $1.050K $1.970K $380.00
YoY Change 5.0% 418.42% 245.45%
% of Gross Profit 0.71% 1.11% 0.12%
Operating Expenses $221.4K $254.2K $262.9K
YoY Change 2.91% -3.3% 7.37%
Operating Profit -$72.92K -$76.45K $53.69K
YoY Change 43.32% -242.4% -376.9%
Interest Expense $5.480K $5.590K $5.180K
YoY Change -34.61% 7.92% 777.97%
% of Operating Profit 9.65%
Other Income/Expense, Net
YoY Change
Pretax Income -$67.44K -$70.86K $58.87K
YoY Change 58.67% -220.37% -413.14%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$67.44K -$70.86K $58.87K
YoY Change 58.67% -220.37% -413.14%
Net Earnings / Revenue -22.94% -21.24% 10.06%
Basic Earnings Per Share -$0.01 -$0.01 $0.01
Diluted Earnings Per Share -$0.01 -$0.01 $0.01
COMMON SHARES
Basic Shares Outstanding 4.947M shares 4.947M shares 4.947M shares
Diluted Shares Outstanding 4.947M shares 4.947M shares 4.947M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $558.2K $722.6K $782.1K
YoY Change -32.05% -7.6% -20.11%
Cash & Equivalents $158.2K $322.6K $382.1K
Short-Term Investments $400.0K $400.0K $400.0K
Other Short-Term Assets $29.68K $20.96K $82.73K
YoY Change -8.51% -74.66% 357.58%
Inventory $785.8K $748.3K $840.6K
Prepaid Expenses $29.68K $20.96K $19.73K
Receivables $59.37K $76.32K $177.9K
Other Receivables $1.340K $1.240K $700.00
Total Short-Term Assets $1.434M $1.569M $1.884M
YoY Change -18.61% -16.69% 11.72%
LONG-TERM ASSETS
Property, Plant & Equipment $16.45K $17.50K $70.72K
YoY Change -14.59% -75.25% 550.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $16.45K $27.87K $70.72K
YoY Change -72.62% -60.6% 550.0%
TOTAL ASSETS
Total Short-Term Assets $1.434M $1.569M $1.884M
Total Long-Term Assets $16.45K $27.87K $70.72K
Total Assets $1.451M $1.597M $1.955M
YoY Change -20.39% -18.28% 15.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.75K $74.12K $93.79K
YoY Change -33.23% -20.98% 137.2%
Accrued Expenses $25.68K $52.42K $96.05K
YoY Change -66.86% -45.42% 321.83%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $47.43K $126.5K $189.8K
YoY Change -56.9% -33.35% 136.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.05K
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $10.05K
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.43K $126.5K $189.8K
Total Long-Term Liabilities $0.00 $0.00 $10.05K
Total Liabilities $47.43K $126.5K $199.9K
YoY Change -56.9% -36.7% 149.39%
SHAREHOLDERS EQUITY
Retained Earnings $465.3K $532.8K $816.7K
YoY Change -39.9% -34.77%
Common Stock $4.947K $4.947K $4.947K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.403M $1.471M $1.755M
YoY Change
Total Liabilities & Shareholders Equity $1.451M $1.597M $1.955M
YoY Change -20.39% -18.28% 15.17%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$67.44K -$70.86K $58.87K
YoY Change 58.67% -220.37% -413.14%
Depreciation, Depletion And Amortization $1.050K $1.970K $380.00
YoY Change 5.0% 418.42% 245.45%
Cash From Operating Activities -$164.4K -$111.2K -$51.25K
YoY Change -517.42% 117.05% -57.87%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.300K $10.77K
YoY Change -87.93%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$148.3K
YoY Change -100.0% -1.13%
Cash From Investing Activities $0.00 -$1.300K -$159.1K
YoY Change -99.18% 6.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -164.4K -111.2K -51.25K
Cash From Investing Activities 0.000 -1.300K -159.1K
Cash From Financing Activities 0.000
Net Change In Cash -164.4K -112.5K -210.3K
YoY Change -517.42% -46.49% -22.58%
FREE CASH FLOW
Cash From Operating Activities -$164.4K -$111.2K -$51.25K
Capital Expenditures $0.00 $1.300K $10.77K
Free Cash Flow -$164.4K -$112.5K -$62.02K
YoY Change -517.42% 81.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10521 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
25631 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
4947 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1597361 usd
CY2024Q2 us-gaap Revenues
Revenues
333569 usd
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30773 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
21243 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4946502 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4946502 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4946502 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4946502 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4947 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
933105 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
933105 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
532772 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
689206 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1470824 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1627258 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1731038 usd
CY2023Q2 us-gaap Revenues
Revenues
585206 usd
us-gaap Revenues
Revenues
689630 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
155809 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
268636 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
316524 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
177760 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
316570 usd
us-gaap Gross Profit
GrossProfit
373106 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62670 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61492 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
151448 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35080 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28021 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
64027 usd
CY2024Q2 us-gaap Marketing Expense
MarketingExpense
156462 usd
CY2023Q2 us-gaap Marketing Expense
MarketingExpense
173368 usd
us-gaap Marketing Expense
MarketingExpense
325127 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
254212 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
262881 usd
us-gaap Operating Expenses
OperatingExpenses
540602 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-76452 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
53689 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-167496 usd
CY2024Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
5592 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
5181 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
11062 usd
CY2024Q2 us-gaap Other Income
OtherIncome
5592 usd
CY2023Q2 us-gaap Other Income
OtherIncome
5181 usd
us-gaap Other Income
OtherIncome
11062 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70860 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
58870 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-156434 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-70860 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
58870 usd
us-gaap Net Income Loss
NetIncomeLoss
-156434 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4946502 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4946502 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4946502 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4946502 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4946502 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4946502 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4946502 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4946502 shares
us-gaap Profit Loss
ProfitLoss
-156434 usd
us-gaap Profit Loss
ProfitLoss
-33254 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2057 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
418 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
693 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23730 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
36474 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
25887 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
115095 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-671 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-109 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1683 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-22901 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
36762 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-45207 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
5930 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4956 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-162314 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-200953 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1304 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19769 usd
us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
700000 usd
us-gaap Proceeds From Payments For In Interest Bearing Deposits In Banks
ProceedsFromPaymentsForInInterestBearingDepositsInBanks
751699 usd
us-gaap Payments For Proceeds From Other Interest Earning Assets
PaymentsForProceedsFromOtherInterestEarningAssets
700000 usd
us-gaap Payments For Proceeds From Other Interest Earning Assets
PaymentsForProceedsFromOtherInterestEarningAssets
900000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1304 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-168070 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-163618 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-369023 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
486252 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751118 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
322634 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
382095 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1787348 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-92124 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1695224 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
58870 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
693 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1754787 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1627258 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-85574 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1541684 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-70860 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1470824 usd
CY2024Q2 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
102952 usd
CY2023Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
118472 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
386694 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
313597 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
258698 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
290388 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
748344 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
722457 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
225000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
225000 shares
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
693 usd
us-gaap Share Based Compensation
ShareBasedCompensation
693 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-001090-index-headers.html Edgar Link pending
0001079973-24-001090-index.html Edgar Link pending
0001079973-24-001090.txt Edgar Link pending
0001079973-24-001090-xbrl.zip Edgar Link pending
elst-20240630.xsd Edgar Link pending
elst_10q.htm Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
elst_10q_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
elst-20240630_cal.xml Edgar Link unprocessable
elst-20240630_def.xml Edgar Link unprocessable
elst-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elst-20240630_lab.xml Edgar Link unprocessable